CERE
Cerevel Therapeutics Holdings, Inc.
Chief Medical Officer Ramiro Sanchez sold $425K of Cerevel Therapeutics Holdings, Inc.
Sold$424,700
$42.47Price
10,000Shares
−41%Stake
What CERE did after the filing
- The stock from Thu, Dec 28 close, $42.44
- +1.6%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Feb 12 close.
Traded Tue, Dec 26. Filed Thu, Dec 28, 11:15 AM ET, during the session. Returns use the Dec 28 close and the Feb 12 close. Not investment advice.